Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02377921
Brief Title: Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM) (GNEM)

First Submitted : February 27, 2015
First Submitted that Met QC Criteria : March 3, 2015
First Posted : March 4, 2015 (Estimate)

Results First Submitted : June 7, 2018
Results First Submitted that Met QC Criteria : June 7, 2018
Results First Posted : July 9, 2018

Last Update Submitted that Met QC Criteria : June 11, 2019
Last Update Posted : June 27, 2019